The Friday Five: Slim Chance for Peace in Ukraine
With Russia winning on the battlefield and Volodomyr Zelensky still insisting on a return to pre-2014 borders, the odds of lasting peace in Ukraine look slim.Continue Reading
With Russia winning on the battlefield and Volodomyr Zelensky still insisting on a return to pre-2014 borders, the odds of lasting peace in Ukraine look slim.Continue Reading
Al Qaeda offshoot HTS and the Kurdish-led SDF have agreed to put aside differences and form a coalition government in Syria.Continue Reading
President Trump delivered his State of the Union address last night, highlighting a number of achievements and outlining policy goals—including a balanced federal budget by 2028. Continue Reading
It took four days, 15 votes, and a lot of concessions to House conservatives, but Rep. Kevin McCarthy is the new Speaker of the U.S. House of Representatives.
France has announced it plans to send light tanks to Ukraine while the Biden administration is considering sending Bradley fighting vehicles, marking the first time Western-made armor would be deployed against Russian troops in Ukraine.Continue Reading
The $1.7 trillion omnibus spending bill signed by President Biden prohibits using Border Patrol funding to improve border security, but gives $410 million to Jordan, Lebanon, Egypt, Tunisia, and Oman—for border security.Continue Reading
The congressional committee investigating the riot at the U.S. Capitol January 6, 2021 is claiming nearly unlimited power to obtain information on private citizens, ignoring limits defined by the Constitution and a pair of McCarthy-era Supreme Court rulings.Continue Reading
New York Gov. Kathy Hochul told a Christian congregation last week that those who aren’t vaccinated “aren’t listening to God.”Continue Reading
It might be less than three weeks away if Congress doesn’t raise the debt ceiling. Democrats and Republicans are playing a game of chicken over massive spending bills that threaten to drive the country even deeper into debt with no plan to begin paying it off.
Pfizer this week announced trials on a new drug to prevent COVID. The drug is described as a “protease inhibitor antiviral therapy”—just like the cheap, widely available drug Ivermectin.Continue Reading
© 2025 Gilbert House